Stay updated on CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial
Sign up to get notified when there's something new on the CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial page.

Latest updates to the CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial page
- Check3 days agoChange DetectedThe page now displays Revision: v3.3.4 instead of v3.3.3.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedFooter now displays Revision: v3.3.3; the HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded a note that PubMed publications are automatically populated and may not be about the study. The page now shows a revision label: Revision: v3.3.2.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved a general funding-status notice about government funding and operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check74 days agoChange DetectedThe page content appears unchanged; there are no additions or deletions affecting the study details, eligibility criteria, or outcomes.SummaryDifference0.4%

- Check103 days agoChange DetectedMajor change: version updated to v3.2.0 with a government-operational status notice; previous version v3.1.0 was removed.SummaryDifference3%

Stay in the know with updates to CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial page.